Table 3 | Effects of potassium-adaptation on urine..

Treatment	Na⁺	K⁺	HCO₃^-	Cl^-
C (2ml/kg)	247.8±11.21	33.9±2.89	22.5±4.33	53.2±5.98
A	234.0±18.08	26.7±4.54	54.4±6.61^b,ad	42.4±7.32
G	123.6±3.90^a,ad	35.8±1.45	19.6±2.12^ad	32.5±6.20^b
AG	227.0±10.02	34.4±2.75	30.2±2.06	54.4±5.50
K	223.0±30.98	26.6±2.70	70.4±6.17^b	39.6±7.39
KAG	236.4±0.60	35.6±2.35 ^ac	34.2±2.15 ^ac	61.6±6.49 ^ac
D	124.8±5.08 ^a	34.0±2.52	9.0±1.73 ^a	49.6±3.82
DG	199.4±13.18^ab	34.9±3.54	59.8±5.06^ab	41.0±7.13
DGA	216.4±21.75	19.4±1.59	28.4±1.21	46.8±7.39
KDGA	237.0±9.32	31.9±1.94^ab	28.4±1.21	60.4±3.76

Values are mean + SEM.
(n=5 per group).
^bp<0.05 significantly different from the control. ^abp<0.05 significantly different from the diabetic group treated with glibenclamide and amlodipine , ^acp<0.05 significantly
different from the potassium adapted group and ^cp<0.05 significantly different from the normal group treated with amlodipine and glibenclamide.
C: Control (normal saline group)
A: Normal group treated with amlodipine
G : Normal group treated with glibenclamide
AG: Normal group treated with both amlodipine and glibenclamide
K: Potassium adapted group
KAG: Potassium adapted treated with both glibenclamide and amlodipine
D: Diabetic group
DG: Diabetic group treated with glibenclamide
DGA: Non-adapted diabetic group treated with both glibenclamide and amlodipine
KDAG: potassium adapted diabetic group treated with both amlodipine and glibenclamide

Table 3: Effects of potassium-adaptation on urine electrolytes of normal and streptozotocin- induced diabetic rats treated with glibenclamide (5 mg/kg) and amlodipine (5 mg/kg).

Goto home»